USANA Health Sciences (NYSE:USNA) Issues Quarterly Earnings Results, Misses Expectations By $0.22 EPS
by Mitch Edgeman · The Markets DailyUSANA Health Sciences (NYSE:USNA – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.22), FiscalAI reports. The firm had revenue of $205.89 million during the quarter, compared to analysts’ expectations of $217.42 million. USANA Health Sciences had a negative net margin of 2.43% and a positive return on equity of 3.41%.
USANA Health Sciences Price Performance
USNA traded up $0.19 on Tuesday, reaching $14.91. 290,210 shares of the company’s stock were exchanged, compared to its average volume of 148,543. The stock’s fifty day moving average price is $14.57 and its 200-day moving average price is $18.10. The stock has a market cap of $275.46 million, a PE ratio of -12.32, a P/E/G ratio of 1.60 and a beta of 0.68. USANA Health Sciences has a twelve month low of $12.57 and a twelve month high of $23.59.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently commented on the company. Zacks Research upgraded USANA Health Sciences from a “strong sell” rating to a “hold” rating in a research report on Monday, October 5th. Weiss Ratings restated a “sell (d)” rating on shares of USANA Health Sciences in a research report on Monday, September 21st. Finally, Wall Street Zen downgraded USANA Health Sciences from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Reduce”.
Check Out Our Latest Report on USANA Health Sciences
About USANA Health Sciences
USANA Health Sciences, Inc develops and sells nutritional supplements, healthy foods and personal-care products through a direct-selling business model. Its product portfolio includes vitamins and mineral supplements, meal-replacement and snack products, sports nutrition offerings, and skincare products marketed under the USANA and related brands.
Founded in 1992 by microbiologist and immunologist Myron W. Wentz, the company is headquartered in Salt Lake City, Utah. USANA distributes its products through a network of independent associates and preferred customers rather than primarily through traditional retail channels.
The company serves customers in markets across the Americas, Asia-Pacific and Europe, with a significant presence in countries including the United States, Canada, Australia, New Zealand, China, Hong Kong, Japan, South Korea, the Philippines, Singapore, Malaysia and Thailand.
Featured Stories
- Five stocks we like better than USANA Health Sciences
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test